BioNxt Solutions Inc. (CVE:BNXT) | WebDisclosure

Basculer en Français

9815	Companies
196879	Keywords
127951	Articles
104707	Press releases

Headlines Articles Press releases BioNxt Solutions Inc.

Home
Companies
BioNxt Solutions Inc.

PRESS RELEASE

published on 12/19/2024 at 09:05, 1 year 1 month ago

BioNxt Solutions Expands Patent Protection for Drug Delivery Innovations Backed by Positive IPRP
BioNxt Solutions Inc. expands its intellectual property portfolio with new international patents for sublingual delivery technologies targeting autoimmune neurodegenerative diseases. The company aims to bring patient-friendly therapies to individuals affected by these diseases

BioNxt Solutions Inc. Intellectual Property Patents Autoimmune Neurodegenerative Diseases Sublingual Delivery Technologies
BRIEF

published on 12/09/2024 at 09:10, 1 year 1 month ago

BioNxt Solutions Advances BNT23001 for MS Treatment

Clinical Trials Drug Development Multiple Sclerosis BioNxt Solutions BNT23001
BRIEF

published on 12/09/2024 at 09:10, 1 year 1 month ago

BioNxt Solutions développe le BNT23001 pour le traitement de la sclérose en plaques

Essais Cliniques Sclérose En Plaques Développement De Médicaments Solutions BioNxt BNT23001
PRESS RELEASE

published on 12/09/2024 at 09:05, 1 year 1 month ago

BioNxt Solutions Reports Progress on BNT23001 Development for Multiple Sclerosis Treatment
BioNxt Solutions Inc. achieves key milestones in the development of BNT23001, a sublingual thin-film formulation of Cladribine for Multiple Sclerosis treatment, paving the way for clinical trials and regulatory submissions in 2025

Clinical Trials BioNxt Solutions Inc. Multiple Sclerosis Sublingual Thin-Film BNT23001
BRIEF

published on 12/02/2024 at 09:10, 1 year 2 months ago

BioNxt Solutions Develops Sublingual Thin-Film for Semaglutide

Drug Delivery Innovation BioNxt Solutions Patient Compliance Sublingual Thin-Film Semaglutide
BRIEF

published on 12/02/2024 at 09:10, 1 year 2 months ago

BioNxt Solutions développe un film mince sublingual pour le sémaglutide

Solutions BioNxt Conformité Des Patients Semaglutide Couche Mince Sublinguale Innovation Dans L'administration Des Médicaments
PRESS RELEASE

published on 12/02/2024 at 09:05, 1 year 2 months ago

BioNxt Solutions Announces Development of Sublingual Thin-Film for Semaglutide
BioNxt Solutions Inc. introduces sublingual thin-film oral dissolvable film (ODF) for Semaglutide, enhancing patient experience and improving drug delivery

Innovation Healthcare BioNxt Solutions Inc. Drug Delivery Semaglutide
BRIEF

published on 11/25/2024 at 09:10, 1 year 2 months ago

BioNxt Expands Sublingual Product Pipeline with Innovations

BioNxt Solutions Sublingual Technology Autoimmune Treatments Longevity Market Drug Delivery Systems
BRIEF

published on 11/25/2024 at 09:10, 1 year 2 months ago

BioNxt élargit sa gamme de produits sublinguaux avec des innovations

Solutions BioNxt Technologie Sublinguale Traitements Auto-immuns Marché De La Longévité Systèmes D'administration De Médicaments
PRESS RELEASE

published on 11/25/2024 at 09:05, 1 year 2 months ago

BioNxt Announces Enhanced Sublingual Product Development Pipeline with Innovative Solutions for Autoimmune Diseases and Longevity
BioNxt Solutions Inc. expands next-gen product pipeline targeting autoimmune diseases & longevity market. Innovative drug delivery systems show promise in major high-growth markets

BioNxt Solutions Inc. Next-Generation Technologies Autoimmune Diseases Longevity Market Drug Delivery Systems

Accesswire

Published on 02/05/2026 at 18:50, 1 hour 43 minutes ago

Athena Gold Provides Exploration Update From Nevada and Ontario
Published on 02/05/2026 at 17:35, 2 hours 58 minutes ago

Pentagon I Capital Corp. Enters into Letter Agreement to Complete Qualifying Transaction with Prospectiva Resources Ltd.
Published on 02/05/2026 at 16:40, 3 hours 53 minutes ago

Relevant Gold Appoints Larry Taddei to Board of Directors and Mal Karwowska as Strategic Advisor
Published on 02/05/2026 at 15:45, 4 hours 48 minutes ago

American Critical Minerals Recaps a Highly Successful 6 Months and Files Amended and Restated Technical Report
Published on 02/05/2026 at 15:10, 5 hours 23 minutes ago

Electric Metals (USA) Limited Announces Change of Auditor

View all ACCESSWIRE

EQS Group

Published on 02/05/2026 at 19:27, 1 hour 5 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 02/05/2026 at 18:46, 1 hour 47 minutes ago

EQS-Adhoc: Mayr-Melnhof Karton AG: Impairment requirements impact profit for the financial year 2025
Published on 02/05/2026 at 18:09, 2 hours 24 minutes ago

Funding Circle Holdings plc: POS-Transaction in Own Shares
Published on 02/05/2026 at 17:55, 2 hours 38 minutes ago

Piramal Critical Care and Blue-Zone Technologies collaborate to capture, collect and recycle waste anaesthesia gas
Published on 02/05/2026 at 17:40, 2 hours 53 minutes ago

BROADPEAK SA: Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social au 01.02.26.

Les Echos

Published on 02/05/2026 at 19:24, 1 hour 8 minutes ago

Minutes of the Combined General Meeting
Published on 02/05/2026 at 19:24, 1 hour 8 minutes ago

Compte-Rendu de l’Assemblée Générale Mixte
Published on 02/05/2026 at 19:15, 1 hour 18 minutes ago

ALTAREA : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 02/05/2026 at 19:15, 1 hour 18 minutes ago

ALTAREA : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES JANVIER 2026
Published on 02/05/2026 at 19:15, 1 hour 18 minutes ago

ALTAREIT : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL

View all LES ECHOS COMFI WIRE